BioHarvest Sciences (XCNQ:BHSC) ROCE % : 0.00% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is BioHarvest Sciences ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. BioHarvest Sciences's annualized ROCE % for the quarter that ended in Mar. 2024 was 0.00%.

BioHarvest Sciences ROCE % Historical Data

The historical data trend for BioHarvest Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioHarvest Sciences ROCE % Chart

BioHarvest Sciences Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-146.81

-130.98

-168.67

-415.29

BioHarvest Sciences Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															-	-	-	-	-

BioHarvest Sciences ROCE % Calculation

BioHarvest Sciences's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-14.225	/	( ( (12.76 - 15.649)	+	(20.127 - 35.508) )	/ 2 )
	=	-14.225	/	( (-2.889	+	-15.381)	/ 2 )
	=	-14.225	/	-9.135
	=	155.72 %

BioHarvest Sciences's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-7.712	/	( ( (20.127 - 35.508)	+	(17.479 - 18.025) )	/ 2 )
	=	-7.712	/	( ( -15.381	+	-0.546 )	/ 2 )
	=	-7.712	/	-7.9635
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

BioHarvest Sciences (XCNQ:BHSC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

BioHarvest Sciences ROCE % Related Terms

Thank you for viewing the detailed overview of BioHarvest Sciences's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

BioHarvest Sciences (XCNQ:BHSC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioHarvest Sciences Inc (XCNQ:BHSC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

CNVCF:USA 8MV:Germany

Address

1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6

Website

https://www.bioharvest.com

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

BioHarvest Sciences (XCNQ:BHSC) Headlines

No Headlines